Robotic-assisted versus conventional laparoscopic surgery in the management of obese patients with early endometrial cancer in the sentinel lymph node era: a randomized controlled study (RObese)Giorgia Dinoi, Vincenzo Tarantino, Nicolò Bizzarri, Emanuele Perrone, Ilaria Capasso, Diana Giannarelli, Denis Querleu, Maria Consiglia Giuliano, Anna Fagotti, Giovanni Scambia, Francesco Fanfani
7 February 2024
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trialTine Ottenbourgs, Toon van Gorp, Frédéric Kridelka, Thaïs Baert, Hannelore Denys, Frédéric Selle, Inge Baas, Anne-Sophie Van Rompuy, Diether Lambrechts, Els Van Nieuwenhuysen
6 March 2024
Secondary cytoreduction surgery for recurrent epithelial ovarian cancer patients after PARPi maintenance: A multicenter, randomized, controlled clinical trialTingting Chen, Junfen Xu, Bairong Xia, Hui Wang, Yuanming Shen
30 December 2023
AGO-OVAR 28/ENGOT-ov57. Niraparib alone versus niraparib in combination with bevacizumab in patients with carboplatin-taxane-based chemotherapy in advanced ovarian cancer: a multicenter randomized phase III trialFlorian Heitz, Christian Marth, Stéphanie Henry, Alexander Reuss, David Cibula, Lydia Gaba Garcia, Nicoletta Colombo, Barbara Schmalfeld, Nikolaus de Gregorio, Pauline Wimberger, Annette Hasenburg, Jalid Sehouli, Martina Gropp-Meier, Philip C Schouten, Eric HahnenSee the full list of authors
7 November 2023
PErsonalized TReatment for Endometrial Carcinoma (PETREC): study design and methods of a prospective Finnish multicenter trialMikko Loukovaara, Ralf Bützow, Synnöve Staff, Minna Mäenpää, Mária Faltinová, Heini Lassus, Olga Veijalainen, Maiju Grönvall, Leila Vaalavirta, Elina Kuikka, Marjut Haataja, Elina Urpilainen, Marja Simojoki, Maarit Anttila, Annika Auranen
9 October 2023
Side effects screening and early intervention to impact in quality of life of patients with gynecological cancers (HALIS study)Blanca Gil-Ibanez, Alvaro Tejerizo-Garcia, M Reyes Oliver, Ainhoa Madariaga, Maria Maiz Jimenez, Alejandra Gil Garcia, Gregorio Lopez-Gonzalez
24 September 2023
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancerRobert W Holloway, Premal Thaker, Alberto A Mendivil, Sarfraz Ahmad, Ahmed N Al-Niaimi, James Barter, Tiffany Beck, Setsuko K Chambers, Robert L Coleman, Sarah M Crafton, Erin Crane, Ramez Eskander, Sharad Ghamande, Whitney Graybill, Thomas HerzogSee the full list of authors
4 September 2023
The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial designMelisa Guelhan Inci, Jalid Sehouli, Eva Schnura, Marlene Lee, Stephanie Roll, Thomas Reinhold, Julia Klews, Lutz Kaufner, Phil Niggemann, Harald Groeben, Julia Toelkes, Anett Reisshauer, Max Liebl, Enrico Daehnert, Manuela ZimmermannSee the full list of authors
19 May 2023
A prospective randomized controlled trial evaluating the safety and efficacy of patient blood management program in patients with gynecologic cancer (KGOG 4011/PBM)Jeong-Yeol Park, Ok Ju Kang, Yoo-Young Lee, Young Seok Kim
24 April 2023
TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocolMiranda P Steenbeek, Majke H D van Bommel, Joanna intHout, Christine B Peterson, Michiel Simons, Kit C B Roes, Marleen Kets, Barbara M Norquist, Elizabeth M Swisher, Rosella P M G Hermens, the TUBA-WISP II consortium, Karen H Lu, Joanne A de Hullu, the TUBA-WISP II consortium, Johan BultenSee the full list of authors
12 April 2023